Cyteir Secures $80 Million Series C Financing to Advance Novel Cancer Therapy Program
by David E Shaw
As a co-founder of Cyteir Therapeutics, and chair emeritus of The Jackson Laboratory where this technology originated with Dr. Kevin Mills, I share news of Cyteir’s $80mm Series C financing. And I send congratulations to the Cyteir team for their remarkable accomplishments!
Read Cyteir’s press release